These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25197055)

  • 1. Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma.
    Robert F; Roman W; Bramoullé A; Fellmann C; Roulston A; Shustik C; Porco JA; Shore GC; Sebag M; Pelletier J
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13421-6. PubMed ID: 25197055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis.
    Lin CJ; Nasr Z; Premsrirut PK; Porco JA; Hippo Y; Lowe SW; Pelletier J
    Cell Rep; 2012 Apr; 1(4):325-33. PubMed ID: 22573234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
    Boussemart L; Malka-Mahieu H; Girault I; Allard D; Hemmingsson O; Tomasic G; Thomas M; Basmadjian C; Ribeiro N; Thuaud F; Mateus C; Routier E; Kamsu-Kom N; Agoussi S; Eggermont AM; Désaubry L; Robert C; Vagner S
    Nature; 2014 Sep; 513(7516):105-9. PubMed ID: 25079330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
    Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
    Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.
    Oblinger JL; Burns SS; Akhmametyeva EM; Huang J; Pan L; Ren Y; Shen R; Miles-Markley B; Moberly AC; Kinghorn AD; Welling DB; Chang LS
    Neuro Oncol; 2016 Sep; 18(9):1265-77. PubMed ID: 26951381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A.
    Cencic R; Robert F; Galicia-Vázquez G; Malina A; Ravindar K; Somaiah R; Pierre P; Tanaka J; Deslongchamps P; Pelletier J
    Blood Cancer J; 2013 Jul; 3(7):e128. PubMed ID: 23872707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation.
    Rubio CA; Weisburd B; Holderfield M; Arias C; Fang E; DeRisi JL; Fanidi A
    Genome Biol; 2014; 15(10):476. PubMed ID: 25273840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction.
    Descamps G; Gomez-Bougie P; Tamburini J; Green A; Bouscary D; Maïga S; Moreau P; Le Gouill S; Pellat-Deceunynck C; Amiot M
    Br J Cancer; 2012 May; 106(10):1660-7. PubMed ID: 22510748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway.
    Wu Y; Wang H
    J Biochem Mol Toxicol; 2018 Jan; 32(1):. PubMed ID: 29205703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. eIF4F: a retrospective.
    Merrick WC
    J Biol Chem; 2015 Oct; 290(40):24091-9. PubMed ID: 26324716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype.
    Issaenko OA; Bitterman PB; Polunovsky VA; Dahlberg PS
    Cancer Gene Ther; 2012 Sep; 19(9):609-18. PubMed ID: 22767218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication.
    Zhou X; Xu L; Wang Y; Wang W; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
    Antiviral Res; 2015 Dec; 124():11-9. PubMed ID: 26526587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the eIF4F translation initiation complex for cancer therapy.
    Konicek BW; Dumstorf CA; Graff JR
    Cell Cycle; 2008 Aug; 7(16):2466-71. PubMed ID: 18719377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.
    Pelletier J; Graff J; Ruggero D; Sonenberg N
    Cancer Res; 2015 Jan; 75(2):250-63. PubMed ID: 25593033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes.
    Robert F; Cencic R; Cai R; Schmeing TM; Pelletier J
    Nucleic Acids Res; 2020 Sep; 48(15):8562-8575. PubMed ID: 32749456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eukaryotic initiation factor (eIF) 4F binding to barley yellow dwarf virus (BYDV) 3'-untranslated region correlates with translation efficiency.
    Banerjee B; Goss DJ
    J Biol Chem; 2014 Feb; 289(7):4286-94. PubMed ID: 24379412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of small molecules targeting eIF4A.
    Naineni SK; Itoua Maïga R; Cencic R; Putnam AA; Amador LA; Rodriguez AD; Jankowsky E; Pelletier J
    RNA; 2020 May; 26(5):541-549. PubMed ID: 32014999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
    Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
    Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid and oxygen effects on eIF4F complex, mTOR, and ENaC translation in fetal lung epithelia.
    Otulakowski G; Duan W; Gandhi S; O'brodovich H
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):457-66. PubMed ID: 17556672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eukaryotic translation initiation factor 4F architectural alterations accompany translation initiation factor redistribution in poxvirus-infected cells.
    Walsh D; Arias C; Perez C; Halladin D; Escandon M; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Mohr I
    Mol Cell Biol; 2008 Apr; 28(8):2648-58. PubMed ID: 18250159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.